Available Technology

Microfluidic Ultrasonic Particle Separators with Engineered Node Locations and Geometries

BACKGROUND
Extraction of nucleic acid from cells or viruses is a necessary task for many applications in the fields of molecular biology and biomedical diagnostics. The chemical and physical methods used for the extraction of nucleic acid suffer from various disadvantages such as  inefficient cell lysis, poor recovery of nucleic acids, damage to cellular contents and sticking of denatured proteins to the released nucleic acids and interfering in downstream processing and/or assays. The following invention uses ultrasonic disruption to overcome the drawbacks of chemical and physical cell lysis methods.

 

 

 

 

 

 

 

 

DESCRIPTION

LLNL has invented a new high-throughput assay for sample separation that overcomes above disadvantages. The present invention uses the vibrations of a piezoelectric transducer to produce acoustic radiation forces within microfluidic channels. The system includes a separation channel for conveying a sample fluid containing the different size particles, an acoustic transducer and a recovery fluid stream. The polymeric films containing the fluid would be sealed upon application of heat and further partitioned into individual microliter or picoliter samples. This approach would allow for the purification, separation, and fractionation of different types of particles (viruses, proteins, nuclei acids, etc.) from complex biological samples suspended in a sample fluid. The technology also minimizes the reaction and process time of the samples.

The figure shows a top-view of the microfluidic chip showing the H-filter geometry.

 

 

 

ADVANTAGES

  • Uses acoustic waves to disrupt cells
  • Overcomes the drawbacks of chemical and physical cell lysis methods
  • High throughput

POTENTIAL APPLICATIONS

  • Continuous flow and processing of Samples
  • Biological pathogen detection and identification
  • Development of personalized medical therapies
  • Biomedical applications, including single-cell analysis, PCR, DNA sequencing, and flow cytometry
  • Diagnostics
  • Food and beverage safety
  • Forensics
  • Chemical separations
  • Drug discovery

DEVELOPMENT STATUS
LLNL has obtained patents (US Patents
8,727,129; 8,991,614; and 9,321,050) covering this technology (LLNL Internal Case # IL-12323).

E-mail
Vaishnav1@llnl.gov

 

 

 

Internal Laboratory Ref #: 
IL - 12323
Lab Representatives
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin